T cells in psoriatic arthritis

[1]  B. Chong,et al.  Immunobiologics in the treatment of psoriasis. , 2007, Clinical immunology.

[2]  S. Colucci,et al.  Lymphocytes and synovial fluid fibroblasts support osteoclastogenesis through RANKL, TNFα, and IL‐7 in an in vitro model derived from human psoriatic arthritis , 2007, The Journal of pathology.

[3]  B. Tom,et al.  A longitudinal study of the effect of disease activity and clinical damage on physical function over the course of psoriatic arthritis: Does the effect change over time? , 2007, Arthritis and rheumatism.

[4]  P. Mease,et al.  Efalizumab for the Treatment of Psoriatic Arthritis , 2007, Journal of cutaneous medicine and surgery.

[5]  B. Nakken,et al.  Circulating cytokines in Norwegian patients with psoriatic arthritis determined by a multiplex cytokine array system. , 2007, Rheumatology.

[6]  D. Baeten,et al.  Published Online First , 2007 .

[7]  D. Gladman,et al.  Predictors for radiological damage in psoriatic arthritis: results from a single centre , 2006, Annals of the rheumatic diseases.

[8]  D. Daoussis,et al.  Increased expression of CD154 (CD40L) on stimulated T-cells from patients with psoriatic arthritis. , 2006, Rheumatology.

[9]  Dafna Gladman,et al.  Classification criteria for psoriatic arthritis: development of new criteria from a large international study. , 2006, Arthritis and rheumatism.

[10]  B. Dijkmans,et al.  Detailed analysis of the cell infiltrate and the expression of mediators of synovial inflammation and joint destruction in the synovium of patients with psoriatic arthritis: implications for treatment , 2006, Annals of the rheumatic diseases.

[11]  E. Wagner,et al.  Corrigendum: Psoriasis-like skin disease and arthritis caused by inducible epidermal deletion of Jun proteins , 2006, Nature.

[12]  B. Grubeck‐Loebenstein,et al.  Between adaptive and innate immunity: TLR4-mediated perforin production by CD28null T-helper cells in ankylosing spondylitis , 2005, Arthritis research & therapy.

[13]  E. Wagner,et al.  Psoriasis-like skin disease and arthritis caused by inducible epidermal deletion of Jun proteins , 2005, Nature.

[14]  James T. Elder,et al.  Genetic epidemiology of psoriasis and psoriatic arthritis , 2005, Annals of the rheumatic diseases.

[15]  D. Veale,et al.  Immunopathology of psoriasis and psoriatic arthritis , 2005, Annals of the rheumatic diseases.

[16]  P. Tak,et al.  Early effects of tumour necrosis factor α blockade on skin and synovial tissue in patients with active psoriasis and psoriatic arthritis , 2004, Annals of the rheumatic diseases.

[17]  R. Langley,et al.  T-Cell Modulation for the Treatment of Chronic Plaque Psoriasis with Efalizumab (Raptiva™): Mechanisms of Action , 2004, Dermatology.

[18]  R. Winchester,et al.  Nucleotide Sequencing of Psoriatic Arthritis Tissue before and during Methotrexate Administration Reveals a Complex Inflammatory T Cell Infiltrate with Very Few Clones Exhibiting Features That Suggest They Drive the Inflammatory Process by Recognizing Autoantigens1 , 2004, The Journal of Immunology.

[19]  A. Menter,et al.  Efalizumab for patients with moderate to severe plaque psoriasis: a randomized controlled trial. , 2003, JAMA.

[20]  M. Lebwohl,et al.  Alefacept-induced decreases in circulating blood lymphocyte counts correlate with clinical response in patients with chronic plaque psoriasis. , 2003, European journal of dermatology : EJD.

[21]  E. Schwarz,et al.  Mechanisms of TNF-alpha- and RANKL-mediated osteoclastogenesis and bone resorption in psoriatic arthritis. , 2003, The Journal of clinical investigation.

[22]  W. Gulliver,et al.  A randomized, double-blind, placebo-controlled phase III study evaluating efficacy and tolerability of 2 courses of alefacept in patients with chronic plaque psoriasis. , 2002, Journal of the American Academy of Dermatology.

[23]  B. Dijkmans,et al.  Alefacept treatment in psoriatic arthritis: reduction of the effector T cell population in peripheral blood and synovial tissue is associated with improvement of clinical signs of arthritis. , 2002, Arthritis and rheumatism.

[24]  M. Allen,et al.  Early migration of cutaneous lymphocyte‐associated antigen (CLA) positive T cells into evolving psoriatic plaques , 2001, Experimental dermatology.

[25]  L. Laloux,et al.  Immunohistological study of entheses in spondyloarthropathies: comparison in rheumatoid arthritis and osteoarthritis , 2001, Annals of the rheumatic diseases.

[26]  M. Kacena,et al.  Control of osteoclastogenesis and bone resorption by members of the TNF family of receptors and ligands. , 2001, Cytokine & growth factor reviews.

[27]  R. Winchester,et al.  Psoriatic Arthritis Joint Fluids Are Characterized by CD8 and CD4 T Cell Clonal Expansions that Appear Antigen Driven1 2 , 2001, The Journal of Immunology.

[28]  C. Tournay,et al.  Specificity of T cells in synovial fluid: high frequencies of CD8+ T cells that are specific for certain viral epitopes , 2000, Arthritis research.

[29]  M. Centola,et al.  Clonal characteristics of T cell infiltrates in skin and synovium of patients with psoriatic arthritis. , 1999, Human immunology.

[30]  B. Bresnihan,et al.  Predominance of CD8+ T lymphocytes in psoriatic arthritis. , 1999, The Journal of rheumatology.

[31]  A. Dunky,et al.  T cell derived cytokines in psoriatic arthritis synovial fluids , 1998, Annals of the rheumatic diseases.

[32]  G. Panayi,et al.  Cutaneous lymphocyte antigen-positive T lymphocytes preferentially migrate to the skin but not to the joint in psoriatic arthritis. , 1996, Arthritis and rheumatism.

[33]  J. Pober,et al.  Inducibility and expression of microvascular endothelial adhesion molecules in lesional, perilesional, and uninvolved skin of psoriatic patients. , 1994, The Journal of investigative dermatology.

[34]  A. Oxholm.  Epidermal expression of interleukin-6 and tumour necrosis factor-alpha in normal and immunoinflammatory skin states in humans. , 1992, APMIS. Supplementum.

[35]  D. Macdonald,et al.  The simultaneous presence of Langerhans' cell and interdigitating cell antigenic markers on inflammatory dendritic cells. , 1986, Clinical and experimental immunology.

[36]  H. Valdimarsson,et al.  T‐cell subpopulations in the blood and skin of patients with psoriasis , 1984, The British journal of dermatology.

[37]  A. Winkelstein.  Principles of immunosuppressive therapy. , 1971, Bulletin on the rheumatic diseases.